Similar companies
| Company | Business Outlook | |
|---|---|---|
 |
AmgenAMGN |
76 2.6% |
 |
Gilead SciencesGILD |
56 3.4% |
 |
Catalyst PharmaceuticalsCPRX |
100 0% |
 |
Inovio PharmaceuticalsINO |
23 0% |
 |
Anavex Life SciencesAVXL |
0 0% |
How do employees feel about the future at CureVac?
According to employees, the Business Outlook at CureVac is highly negative. This is reflected in the average rating of 25 out of 100, which is considered very low. This rating (aggregated from the top review sites in the US) is also down by -7.4% since the previous month.
Analyzing Business Outlook, how is CureVac performing compared to its industry peers?
CureVac underperforms its industry peers when it comes to Business Outlook, ranking in the 25th percentile.
Why is it important to track the business outlook at CureVac?
Tracking a company's business outlook is important as a positive outlook can indicate future growth and profitability and attract new talent, while a negative outlook can discourage talent and imply demotivated employees. Additionally, data shows that companies with a high business outlook tend to perform better on the stock market compared to those with a lower business outlook.
Sign up and get more insights on the business outlook at CureVac.
